Quanterix Corp - Asset Resilience Ratio

Latest as of September 2025: 21.73%

Quanterix Corp (QTRX) has an Asset Resilience Ratio of 21.73% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$96.51 Million
Cash + Short-term Investments

Total Assets

$444.14 Million
All company assets

Resilience Assessment

Good
Financial Resilience Level

Asset Resilience Ratio Trend (2022–2024)

This chart shows how Quanterix Corp's Asset Resilience Ratio has changed over time. Check asset allocation strategy of Quanterix Corp to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Quanterix Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Quanterix Corp (QTRX) market capitalisation.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $96.51 Million 21.73%
Total Liquid Assets $96.51 Million 21.73%

Asset Resilience Insights

  • Good Liquidity Position: Quanterix Corp maintains a healthy 21.73% of assets in liquid form.
  • This level provides good financial flexibility while maintaining productive asset deployment.
  • The company has significant short-term investments, indicating active treasury management.

Quanterix Corp Industry Peers by Asset Resilience Ratio

Compare Quanterix Corp's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Bio-Rad Laboratories Inc
NYSE:BIO
Medical Devices 10.80%
Double Medical Technology Inc
SHE:002901
Medical Devices 12.59%
Tellgen Corp
SHE:300642
Medical Devices 9.96%
Affluent Medical SAS
PA:AFME
Medical Devices 0.03%
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Anteris Technologies Global Corp
AU:AVR
Medical Devices 33.27%
Imricor Medical Systems Inc
AU:IMR
Medical Devices 46.50%
Polynovo Ltd
AU:PNV
Medical Devices 0.04%

Annual Asset Resilience Ratio for Quanterix Corp (2022–2024)

The table below shows the annual Asset Resilience Ratio data for Quanterix Corp.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 57.17% $232.41 Million $406.53 Million +22.89pp
2023-12-31 34.28% $146.90 Million $428.57 Million --
2022-12-31 0.00% $0.00 $433.58 Million --
pp = percentage points

About Quanterix Corp

NASDAQ:QTRX USA Medical Devices
Market Cap
$162.55 Million
Market Cap Rank
#17267 Global
#4044 in USA
Share Price
$3.48
Change (1 day)
-1.14%
52-Week Range
$2.51 - $8.06
All Time High
$90.64
About

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa … Read more